Is granulocyte colony-stimulating factor therapy a risk factor for myelodysplasia/leukemia in patients with congenital neutropenia?

Haematologica. 2005 Jan;90(1):2-3.

Authors

Charlotte M Niemeyer¹, Christian P Kratz

Affiliation

¹ Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany. niemeyer@kikli.ukl.uni-freiburg.de

PMID: 15644298

No abstract available

Publication types

Comment

MeSH terms

Dose-Response Relationship, Drug
Genetic Predisposition to Disease
Granulocyte Colony-Stimulating Factor / administration & dosage
Granulocyte Colony-Stimulating Factor / therapeutic use*
Humans
Injections
Leukemia, Myeloid / complications
Leukemia, Myeloid / epidemiology*
Leukemia, Myeloid / genetics
Neural Tube Defects / complications
Neural Tube Defects / epidemiology*
Neural Tube Defects / genetics
Neutropenia / congenital*
Recombinant Proteins
Risk Factors

Substances

Recombinant Proteins
Granulocyte Colony-Stimulating Factor